Oncobiologics - Stock Price History | OTLK

Historical daily share price chart and data for Oncobiologics since 2021 adjusted for splits. The latest closing stock price for Oncobiologics as of September 27, 2021 is 2.28.
  • The all-time high Oncobiologics stock closing price was 43.36 on September 06, 2016.
  • The Oncobiologics 52-week high stock price is 4.26, which is 86.8% above the current share price.
  • The Oncobiologics 52-week low stock price is 0.68, which is 70.2% below the current share price.
  • The average Oncobiologics stock price for the last 52 weeks is 1.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Oncobiologics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 0.9714 0.8750 1.6000 0.5100 1.3000 120.34%
2019 3.0773 4.4000 10.5600 0.5258 0.5900 -85.25%
2018 7.3613 10.0800 10.0800 3.3800 4.0000 -61.54%
2017 14.5690 26.2560 30.0000 6.6504 10.4000 -56.81%
2016 29.7248 34.1600 43.3600 15.1544 24.0800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.400B $0.008B
Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29